These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17982480)

  • 21. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
    Trotta T; Costantini S; Colonna G
    Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-γ amplifies airway smooth muscle-mediated CD4+ T cell recruitment by promoting the secretion of C-X-C-motif chemokine receptor 3 ligands.
    Sun R; Jang JH; Lauzon AM; Martin JG
    FASEB J; 2021 Jan; 35(1):e21228. PubMed ID: 33337555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
    Hueso L; Ortega R; Selles F; Wu-Xiong NY; Ortega J; Civera M; Ascaso JF; Sanz MJ; Real JT; Piqueras L
    Int J Obes (Lond); 2018 Aug; 42(8):1406-1417. PubMed ID: 29795466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.
    Jenh CH; Cox MA; Cui L; Reich EP; Sullivan L; Chen SC; Kinsley D; Qian S; Kim SH; Rosenblum S; Kozlowski J; Fine JS; Zavodny PJ; Lundell D
    BMC Immunol; 2012 Jan; 13():2. PubMed ID: 22233170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.
    Dagan-Berger M; Feniger-Barish R; Avniel S; Wald H; Galun E; Grabovsky V; Alon R; Nagler A; Ben-Baruch A; Peled A
    Blood; 2006 May; 107(10):3821-31. PubMed ID: 16368892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Mika J
    Data Brief; 2018 Dec; 21():1145-1150. PubMed ID: 30456228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optic neuritis: chemokine receptor CXCR3 and its ligands.
    Sørensen TL; Roed H; Sellebjerg F
    Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
    Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
    BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
    Puchert M; Obst J; Koch C; Zieger K; Engele J
    Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.
    Koper OM; Kamińska J; Sawicki K; Kemona H
    Adv Clin Exp Med; 2018 Jun; 27(6):849-856. PubMed ID: 29893515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration.
    Guo YC; Chiu YH; Chen CP; Wang HS
    Stem Cell Res Ther; 2018 Oct; 9(1):281. PubMed ID: 30359318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis.
    Kohler RE; Comerford I; Townley S; Haylock-Jacobs S; Clark-Lewis I; McColl SR
    Brain Pathol; 2008 Oct; 18(4):504-16. PubMed ID: 18422759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
    J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.